• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性溶血性贫血中的铁过载:铁调素和细胞因子的作用以及铁蛋白和转铁蛋白饱和度的预测价值。

Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.

机构信息

Milano - Unità di Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Spedali Civili di Brescia - Unità di Ematologia, Brescia, Italy.

出版信息

Br J Haematol. 2019 May;185(3):523-531. doi: 10.1111/bjh.15811. Epub 2019 Mar 3.

DOI:10.1111/bjh.15811
PMID:30828802
Abstract

Iron overload (IO) is poorly investigated in the congenital haemolytic anaemias (CHAs), a heterogeneous group of rare inherited diseases encompassing abnormalities of the erythrocyte membrane and metabolism, and defects of the erythropoiesis. In this study we systematically evaluated routine iron parameters and cardiac and hepatic magnetic resonance imaging, together with erythropoietin, hepcidin, non-transferrin bound iron (NTBI), and cytokine serum levels in patients with different CHAs. We found that 40% of patients had a liver iron concentration (LIC) >4 mg Fe/g dry weight. Hepatic IO was associated with ferritin levels (P = 0·0025), transferrin saturation (TfSat, P = 0·002) and NTBI (P = 0·003). Moreover, ferritin >500 μg/l plus TfSat >60% was demonstrated as the best combination able to identify increased LIC, and TfSat alteration as more important in cases with discordant values. Possible confounding factors, such as transfusions, hepatic disease, metabolic syndrome and hereditary haemochromatosis-associated mutations, had negligible effects on IO. Erythropoietin and hepcidin levels were increased in CHAs compared with controls, correlating with LIC and ferritin, respectively. Regarding cytokines, γ-interferon (IFN-γ) was increased, and both interleukin 6 and IFN-γ levels positively correlated with ferritin and hepcidin levels. Overall, these findings suggest the existence of a vicious cycle between chronic haemolysis, inflammatory response and IO in CHAs.

摘要

铁过载(IO)在先天性溶血性贫血(CHAs)中研究甚少,CHAs 是一组罕见的遗传性疾病,包括红细胞膜和代谢异常,以及红细胞生成缺陷。在这项研究中,我们系统地评估了不同 CHAs 患者的常规铁参数、心脏和肝脏磁共振成像以及促红细胞生成素、铁调素、非转铁蛋白结合铁(NTBI)和细胞因子的血清水平。我们发现 40%的患者肝脏铁浓度(LIC)>4mg Fe/g 干重。肝 IO 与铁蛋白水平(P=0·0025)、转铁蛋白饱和度(TfSat,P=0·002)和 NTBI(P=0·003)相关。此外,铁蛋白>500μg/l 加 TfSat>60%被证明是能够识别增加的 LIC 的最佳组合,而在 TfSat 值不一致的情况下,TfSat 的改变更为重要。可能的混杂因素,如输血、肝脏疾病、代谢综合征和遗传性血色素沉着症相关突变,对 IO 的影响可以忽略不计。与对照组相比,CHAs 中的促红细胞生成素和铁调素水平升高,分别与 LIC 和铁蛋白相关。关于细胞因子,γ-干扰素(IFN-γ)增加,且白细胞介素 6 和 IFN-γ水平与铁蛋白和铁调素水平呈正相关。总的来说,这些发现表明在 CHAs 中存在慢性溶血、炎症反应和 IO 之间的恶性循环。

相似文献

1
Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.先天性溶血性贫血中的铁过载:铁调素和细胞因子的作用以及铁蛋白和转铁蛋白饱和度的预测价值。
Br J Haematol. 2019 May;185(3):523-531. doi: 10.1111/bjh.15811. Epub 2019 Mar 3.
2
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.非输血依赖型地中海贫血症中的铁过载:红细胞生成、脾切除术及输血的作用
Br J Haematol. 2017 Jan;176(2):288-299. doi: 10.1111/bjh.14373. Epub 2016 Dec 5.
3
Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.在转诊至肝脏中心的患者中,根据遗传性血色素沉着症基因(HFE)状态分析铁调素与非转铁蛋白结合铁(NTBI)的相关性。
Acta Haematol. 2015;133(2):155-61. doi: 10.1159/000363490. Epub 2014 Sep 26.
4
Hepcidin resistance in dysmetabolic iron overload.代谢异常性铁过载中的铁调素抵抗。
Liver Int. 2016 Oct;36(10):1540-8. doi: 10.1111/liv.13124. Epub 2016 Apr 6.
5
Increased serum iron in preeclamptic women is likely due to low hepcidin levels.子痫前期妇女血清铁升高可能是由于低水平的铁调素。
Nutr Res. 2018 May;53:32-39. doi: 10.1016/j.nutres.2018.03.005. Epub 2018 Mar 21.
6
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.在去铁酮治疗前后不同基础贫血中,除血清铁蛋白外,不稳定血浆铁和转铁蛋白饱和度作为铁过载标志物的效用。
Eur J Haematol. 2016 Jan;96(1):19-26. doi: 10.1111/ejh.12540. Epub 2015 Jun 23.
7
Liver iron concentrations and urinary hepcidin in beta-thalassemia.β地中海贫血患者的肝脏铁浓度和尿铁调素
Haematologica. 2007 May;92(5):583-8. doi: 10.3324/haematol.10842.
8
Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.鲁司非肽治疗HFE相关血色素沉着症铁过载:一项开放标签、多中心、概念验证性2期试验
Lancet Gastroenterol Hepatol. 2023 Dec;8(12):1118-1128. doi: 10.1016/S2468-1253(23)00250-9. Epub 2023 Oct 17.
9
Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.地中海贫血患者的红细胞生成和铁代谢失衡。
Int J Med Sci. 2019 Jan 1;16(2):302-310. doi: 10.7150/ijms.27829. eCollection 2019.
10
Congenital Hemolytic Anemias: Is There a Role for the Immune System?先天性溶血性贫血:免疫系统是否发挥作用?
Front Immunol. 2020 Jun 23;11:1309. doi: 10.3389/fimmu.2020.01309. eCollection 2020.

引用本文的文献

1
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.米他膦酸酯可改善丙酮酸激酶缺乏症成年患者无效红细胞生成和铁过载。
Blood Adv. 2024 May 28;8(10):2433-2441. doi: 10.1182/bloodadvances.2023011743.
2
Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency.评估丙酮酸激酶缺乏症中系统性铁稳态的主要调节剂。
Sci Rep. 2023 Mar 16;13(1):4395. doi: 10.1038/s41598-023-31571-2.
3
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.
从生物学到临床实践:去铁胺螯合疗法
Front Oncol. 2021 Oct 6;11:752192. doi: 10.3389/fonc.2021.752192. eCollection 2021.
4
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias.罕见先天性溶血性贫血的诊断和临床病程中的混杂因素。
Orphanet J Rare Dis. 2021 Oct 9;16(1):415. doi: 10.1186/s13023-021-02036-4.
5
Congenital Hemolytic Anemias: Is There a Role for the Immune System?先天性溶血性贫血:免疫系统是否发挥作用?
Front Immunol. 2020 Jun 23;11:1309. doi: 10.3389/fimmu.2020.01309. eCollection 2020.